Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jun;26(6):612-615.
doi: 10.1111/resp.14062. Epub 2021 Apr 19.

Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID-19

John A Mackintosh  1 , Laura Glenn  2   3 , Hayley Barnes  4 , Emily Dunn  5 , Sandra Bancroft  1 , Taryn Reddy  6 , Alan K Y Teoh  2   3 , Lauren Troy  2 , Helen Jo  2 , Monika Geis  2 , Ian Glaspole  4 , Christopher Grainge  5 , Tamera J Corte  2   3 , Daniel C Chambers  1   7 , Peter Hopkins  1   7
Affiliations
Comment

Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID-19

John A Mackintosh et al. Respirology. 2021 Jun.
No abstract available

Keywords: interstitial lung disease; multidisciplinary meeting; pulmonary fibrosis.

PubMed Disclaimer

Conflict of interest statement

This research was supported by the Australian IPF Registry and funded by the NHMRC Centre of Research Excellence in Pulmonary Fibrosis (funded by Lung Foundation Australia and industry sponsors including: Boehringer Ingelheim, Roche Products Pty. Limited, Galapagos and Bristol‐Myers Squibb Australia). The authors declare that they have no other conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Locations of our centralized ILD‐MDMs and participating clinicians. ILD, interstitial lung disease; MDM, multidisciplinary meeting
See this image and copyright information in PMC

Comment on

References

    1. Wong AW, Fidler L, Marcoux V, Johannson KA, Assayag D, Fisher JH, et al. Practical considerations for the diagnosis and treatment of fibrotic interstitial lung disease during the COVID‐19 pandemic. Chest. 2020;158(3):1069–1078. - PMC - PubMed
    1. Richeldi L, Launders N, Martinez F, Walsh SLF, Myers J, Wang B, et al. The characterisation of interstitial lung disease multidisciplinary team meetings: a global study. ERJ Open Res. 2019;5:1–11. - PMC - PubMed
    1. McLean AEB, Webster SE, Fry M, Lau EM, Corte P, Torzillo PJ, et al. Priorities and expectations of patients attending a multidisciplinary interstitial lung disease clinic. Respirology. 2021;26:80–6. - PubMed
    1. Jo HE, Troy LK, Keir G, Chambers DC, Holland A, Goh N, et al. Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: a position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia. Respirology. 2017;22:1436–58. - PubMed
    1. Fujisawa T, Mori K, Mikamo M, Ohno T, Kataoka K, Sugimoto C, et al. Nationwide cloud‐based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion. Eur Respir J. 2019;53:1–11. - PMC - PubMed